-
INBX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
-
Shorts
Inhibrx Biosciences (INBX)
Company Profile
Quarter (USD) | Sep 24 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 196.33 mm | 196.33 mm | ||||
Cash burn (monthly) | 15.60 mm | (no burn) | ||||
Cash used (since last report) | 43.55 mm | n/a | ||||
Cash remaining | 152.79 mm | n/a | ||||
Runway (months of cash) | 9.8 | n/a |
13F holders | Current |
---|---|
Total holders | 53 |
Opened positions | 53 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 96.20 bn |
Total shares | 8.78 mm |
Total puts | 107.73 k |
Total calls | 155.65 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
Viking Global Investors | 1.79 mm | $25.33 bn |
SNY Sanofi | 1.16 mm | $0.00 |
Perceptive Advisors | 1.06 mm | $15.08 bn |
Jon Faiz Kayyem | 806.08 k | $27.50 mm |
Walleye Capital | 475.00 k | $6.73 bn |
Slotnik Capital | 341.61 k | $4.84 bn |
Millennium Management | 303.20 k | $4.30 bn |
TIG Advisors | 243.65 k | $3.45 bn |
MS Morgan Stanley | 235.92 k | $3.34 bn |
Ikarian Capital | 230.00 k | $3.26 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Dec 24 | Jon Faiz Kayyem | Common Stock | Gift | Acquire G | Yes | No | 0 | 250,000 | 0.00 | 250,000 |
16 Dec 24 | Jon Faiz Kayyem | Common Stock | Gift | Acquire G | Yes | No | 0 | 250,000 | 0.00 | 250,000 |
16 Dec 24 | Jon Faiz Kayyem | Common Stock | Gift | Dispose G | Yes | No | 0 | 500,000 | 0.00 | 509,360 |
6 Dec 24 | Jon Faiz Kayyem | Common Stock | Gift | Dispose G | Yes | No | 0 | 52,000 | 0.00 | 1,009,360 |
20 Nov 24 | Jon Faiz Kayyem | Common Stock | Buy | Acquire P | Yes | No | 14.1921 | 18,750 | 266.10 k | 69,843 |
20 Nov 24 | Jon Faiz Kayyem | Common Stock | Buy | Acquire P | Yes | No | 14.1921 | 18,750 | 266.10 k | 69,843 |
19 Nov 24 | Jon Faiz Kayyem | Common Stock | Buy | Acquire P | Yes | No | 14.2269 | 34,843 | 495.71 k | 51,093 |
19 Nov 24 | Jon Faiz Kayyem | Common Stock | Buy | Acquire P | Yes | No | 14.2269 | 34,843 | 495.71 k | 51,093 |
3 Oct 24 | Vuori Kristiina MD | Common Stock | Buy | Acquire P | No | No | 15 | 6,667 | 100.01 k | 20,443 |
16 Sep 24 | Mark Lappe | Common Stock | Buy | Acquire P | Yes | No | 17.13 | 13,037 | 223.32 k | 705,548 |